Published in Br Med J on May 21, 1966
Latent cytomegalovirus infection in blood donors. Br Med J (1969) 2.61
Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol (1994) 2.31
Isolation of cytomegalovirus and clinical manifestations of infection at different ages. Br Med J (1968) 2.29
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Cytomegalovirus antibody production in renal transplant patients. J Hyg (Lond) (1971) 1.43
Incidence of cytomegaloviremia in blood-bank donors and in infants with congenital cytomegalic inclusion disease. Infect Immun (1971) 1.34
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother (2009) 1.30
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol (1979) 1.25
Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus (CMV) induced in vitro lymphocyte reactivity and its relationship to the production of CMV antibodies. Clin Exp Immunol (1980) 1.22
Immunity to human cytomegalovirus measured and compared by complement fixation, indirect fluorescent-antibody, indirect hemagglutination, and enzyme-linked immunosorbent assays. J Clin Microbiol (1984) 1.19
Cytomegalovirus infection in a volunteer blood donor population. Infect Immun (1975) 1.18
Incidence of ocular complications in patients undergoing renal transplantation. Br Med J (1972) 1.17
Factors contributing to the risk of cytomegalovirus infection in patients receiving renal transplants. Yale J Biol Med (1976) 1.12
Congenital cytomegalic inclusion disease following intrauterine transfusion. Br Med J (1969) 1.08
Cytomegalic inclusion disease in the adult. J Clin Pathol (1968) 1.08
Post-transfusion cytomegaloviremia and persistence of cytomegalovirus in blood. Infect Immun (1971) 1.03
Infectious mononucleosis and mononucleosis syndromes. West J Med (1977) 1.02
Cytomegalovirus infection in children undergoing open-heart surgery. Yale J Biol Med (1976) 0.97
Acquired cytomegalovirus infection. Br Med J (1968) 0.96
Cytomegalovirus infection in early infancy. Five atypical cases. Arch Dis Child (1970) 0.92
The blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody. Yale J Biol Med (1976) 0.90
Herpesviruses. J Clin Pathol (1979) 0.89
Stability of cytomegalovirus antibodies in plasma during prolonged storage of blood components. Clin Diagn Lab Immunol (1995) 0.88
Infectious mononucleosis. Can Med Assoc J (1967) 0.86
Cytomegalovirus infections in the blood recipient. Yale J Biol Med (1976) 0.83
Cytomegalovirus replication and the host immune response. Yale J Biol Med (1976) 0.83
Resistant pathogens, fungi, and viruses. Surg Clin North Am (2014) 0.82
Infectious mononucleosis: current status of candidate virus. Can Med Assoc J (1969) 0.80
Cytomegalovirus-induced haemolytic anaemia after cardiac surgery. Thorax (1976) 0.76
Cytomegalovirus infection. Arch Dis Child (1971) 0.76
Cytomegalovirus-mononucleosis in a newborn infant. Arch Dis Child (1975) 0.75
Patients with cytomegalovirus infection in general practice. J R Coll Gen Pract (1972) 0.75
Cytomegalovirus: a cause of persistent latent infection. J Clin Pathol Suppl (R Coll Pathol) (1972) 0.75
Infection with E.B. virus. Br Med J (1973) 0.75
Infectious-mononucleosis-like syndrome following haemodialysis for carbon tetrachloride poisoning. Postgrad Med J (1968) 0.75
Host-virus relationship with special reference to Newcastle disease and serum hepatitis. J Clin Pathol Suppl (R Coll Pathol) (1972) 0.75
Cytomegalovirus infection. Br Med J (1971) 0.75
Editorial: Cytomegalovirus again. Br Med J (1974) 0.75
Transfusion-associated cytomegalovirus mononucleosis. Ann Surg (1977) 0.75
Cytomegalovirus mononucleosis with urticaria. Postgrad Med J (1975) 0.75
Editorial: Unsuspected cytomegalic mononucleosis. Br Med J (1974) 0.75
Infection risks of haemodialysis--some preventive aspects. A report to the Public Health Laboratory Service by the Working Party on Haemodialysis Units. Br Med J (1968) 0.75
Cytomegalovirus mononucleosis in Chinese infants. Arch Dis Child (1972) 0.75
A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol (1957) 21.03
Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med (1956) 7.35
Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J (1965) 6.04
Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology (1960) 3.36
Fever, splenomegaly and atypical lymphocytes. A syndrome observed after cardiac surgery utilizing a pump oxygenator. N Engl J Med (1962) 2.63
A SYNDROME RESEMBLING INFECTIOUS MONONUCLEOSIS AFTER OPEN-HEART SURGERY. Br Med J (1964) 2.29
Fever, splenomegaly, lymphocytosis and eosinophilia. Yale J Biol Med (1962) 1.30
Fever with a blood picture resembling infectious mononucleosis in operated tuberculous cases. Acta Tuberc Scand (1957) 1.20
[FEBRILE SYNDROME WITH MONONUCLEOSIS-LIKE BLOOD REACTION AFTER THORACIC SURGERY. (CLINICAL ENTITY OBSERVED PARTICULARLY AFTER OPEN-HEART OPERATIONS]. Presse Med (1965) 1.09
Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J (1965) 6.04
Studies in subviral components of Semliki Forest virus. Ann Med Exp Biol Fenn (1969) 3.59
Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol (2005) 3.18
T7 vectors with modified T7lac promoter for expression of proteins in Escherichia coli. Anal Biochem (1996) 3.08
Flaviviridae. Intervirology (1985) 3.06
Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Proc Natl Acad Sci U S A (1995) 2.86
Specific Sindbis virus-coded function for minus-strand RNA synthesis. J Virol (1981) 2.69
Amino acid sequence of alpha-amylase from Bacillus amyloliquefaciens deduced from the nucleotide sequence of the cloned gene. J Biol Chem (1983) 2.54
Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins. J Cell Biol (1980) 2.50
18S defective interfering RNA of Semliki Forest virus contains a triplicated linear repeat. Proc Natl Acad Sci U S A (1981) 2.32
Nucleotide sequence of the promoter and NH2-terminal signal peptide region of the alpha-amylase gene from Bacillus amyloliquefaciens. Gene (1981) 2.30
Membrane fusion mutants of Semliki Forest virus. J Cell Biol (1984) 2.27
The ribonucleic acids of Uukuniemi virus, a noncubical tick-borne arbovirus. Virology (1973) 2.21
Biogenesis of the Semliki Forest virus RNA replication complex. J Virol (2001) 2.21
Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b. J Virol (1983) 2.19
A Sindbis virus mutant temperature-sensitive in the regulation of minus-strand RNA synthesis. Virology (1981) 2.07
Functional defects of RNA-negative temperature-sensitive mutants of Sindbis and Semliki Forest viruses. J Virol (1979) 2.07
Semliki Forest virus mRNA capping enzyme requires association with anionic membrane phospholipids for activity. EMBO J (1999) 2.07
Nuclear localization of Semliki Forest virus-specific nonstructural protein nsP2. J Virol (1990) 1.99
Togaviridae. Intervirology (1985) 1.96
RNA helicase activity of Semliki Forest virus replicase protein NSP2. FEBS Lett (1999) 1.95
Inhibition of cell functions by RNA-virus infections. Annu Rev Microbiol (1984) 1.94
ATPase and GTPase activities associated with Semliki Forest virus nonstructural protein nsP2. J Virol (1994) 1.94
The Guillain-Barré syndrome associated with acquired cytomegalovirus infection. Acta Med Scand (1967) 1.93
Properties of Semliki Forest virus nucleocapsid. 1. Sensitivity to pancreatic ribonuclease. Virology (1971) 1.87
Critical residues of Semliki Forest virus RNA capping enzyme involved in methyltransferase and guanylyltransferase-like activities. J Virol (1997) 1.86
Structure and replication of alpha-viruses. Curr Top Microbiol Immunol (1978) 1.84
Mixed cryoimmunoglobulinaemia in infectious mononucleois and Cytomegalovirus mononucleosis. Int Arch Allergy Appl Immunol (1968) 1.84
Fusion and haemolysis of erythrocytes caused by three togaviruses: Semliki Forest, Sindbis and rubella. J Gen Virol (1980) 1.77
Identification of a novel function of the alphavirus capping apparatus. RNA 5'-triphosphatase activity of Nsp2. J Biol Chem (2000) 1.74
Secretion of Escherichia coli beta-lactamase from Bacillus subtilis by the aid of alpha-amylase signal sequence. Proc Natl Acad Sci U S A (1982) 1.74
Further studies on cytomegalovirus mononucleosis in previously healthy individuals. Acta Med Scand (1967) 1.73
Semliki Forest virus-specific non-structural protein nsP3 is a phosphoprotein. J Gen Virol (1988) 1.71
Secretion of interferon by Bacillus subtilis. Gene (1983) 1.70
Characterization of the Semliki Forest virus core and envelope protein. Biochem Biophys Res Commun (1970) 1.64
Expression of Semliki Forest virus nsP1-specific methyltransferase in insect cells and in Escherichia coli. J Virol (1994) 1.64
The alphavirus replicase protein nsP1 is membrane-associated and has affinity to endocytic organelles. Virology (1995) 1.58
Semliki Forest virus capsid protein associates with the 60S ribosomal subunit in infected cells. J Virol (1976) 1.57
Structural components of Uukuniemi virus, a noncubical tick-borne arbovirus. Virology (1971) 1.56
Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins. J Virol (1984) 1.51
Extreme ends of the genome are conserved and rearranged in the defective interfering RNAs of Semliki Forest virus. J Mol Biol (1982) 1.51
Cytomegalovirus mononucleosis in previously healthy individuals. Five new cases and follow-up of 13 previously published cases. Ann Intern Med (1969) 1.51
Solubilized RNA replication complex from Semliki Forest virus-infected cells. Virology (1979) 1.51
Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis (1970) 1.50
Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis (1971) 1.48
Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol (2001) 1.47
Semliki forest virus mutants with temperature-sensitive transport defect of envelope proteins. Virology (1980) 1.47
IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies. Br Med J (1974) 1.46
Nuclear and nucleolar targeting signals of Semliki Forest virus nonstructural protein nsP2. Virology (1992) 1.46
The effects of palmitoylation on membrane association of Semliki forest virus RNA capping enzyme. J Biol Chem (1996) 1.44
Subclinical cytomegalovirus infections and cytomegalovirus mononculeosis after open heart surgery. Am J Cardiol (1968) 1.43
Isolation and basic characterization of temperature-sensitive mutants from Semliki Forest virus;. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.38
The lipids of the plasma membranes and endoplasmic reticulum from cultured baby hamster kidney cells (BHK21). Biochim Biophys Acta (1972) 1.37
Initiation of translation directed by 42S and 26S RNAs from Semliki Forest virus in vitro. Proc Natl Acad Sci U S A (1976) 1.35
Intracellular distribution of rubella virus nonstructural protein P150. J Virol (1999) 1.32
Incomplete complex oligosaccharides in semliki forest virus envelope proteins arrested within the cell in the presence of monensin. J Mol Biol (1982) 1.32
Proteolytic processing of Semliki Forest virus-specific non-structural polyprotein by nsP2 protease. J Gen Virol (2001) 1.32
Cytomegalo virus--mononucleosis. Isolation of the virus and demonstration of subclinical infections after fresh blood transfusion in connection with open-heart surgery. Ann Med Exp Biol Fenn (1966) 1.30
Haemolysis by two alphaviruses: Semliki Forest and Sindbis virus. J Gen Virol (1979) 1.29
The nucleotide sequences of the 5'-terminal T1 oligonucleotides of Semliki-Forest-virus 42-S and 26-S RNAs are different. Eur J Biochem (1980) 1.27
Nucleotide sequence of the genes coding for the membrane glycoproteins E1 and E2 of rubella virus. J Gen Virol (1987) 1.26
Sequential translation of nonstructural proteins in cells infected with a Semliki Forest virus mutant. Proc Natl Acad Sci U S A (1976) 1.25
Chemical synthesis and molecular cloning of a STOP oligonucleotide encoding an UGA translation terminator in all three reading frames. Gene (1983) 1.24
Biogenesis of type I cytopathic vacuoles in Semliki Forest virus-infected BHK cells. J Virol (1991) 1.24
Site-specific protease activity of the carboxyl-terminal domain of Semliki Forest virus replicase protein nsP2. J Biol Chem (2001) 1.22
Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. N Engl J Med (1970) 1.21
A method for exposing hidden antigenic sites in paraformaldehyde-fixed cultured cells, applied to initially unreactive antibodies. J Histochem Cytochem (1993) 1.19
Regulation of alphavirus 26S mRNA transcription by replicase component nsP2. J Gen Virol (1998) 1.19
Proteins synthesized by Semliki Forest virus and its 16 temperature-sensitive mutants. J Virol (1975) 1.19
Role of protein synthesis in the assembly of Semliki forest virus nucleocapsid. Virology (1979) 1.18
Alphavirus replicase protein NSP1 induces filopodia and rearrangement of actin filaments. J Virol (1998) 1.15
Evidence for a separate signal sequence for the carboxy-terminal envelope glycoprotein E1 of Semliki forest virus. J Virol (1981) 1.13
Nuclear targeting of Semliki Forest virus nsP2. Arch Virol Suppl (1994) 1.13
The phospholipid composition of Uukuniemi virus, a non-cubical tick-borne arbovirus. Virology (1972) 1.13
Elimination of phosphorylation sites of Semliki Forest virus replicase protein nsP3. J Biol Chem (2000) 1.12
Membrane binding mechanism of an RNA virus-capping enzyme. J Biol Chem (2000) 1.11
Semliki Forest virus replication complex capable of synthesizing 42S and 26S nascent RNA chains. J Gen Virol (1980) 1.10
Effective subunit vaccines against an enveloped animal virus. Nature (1978) 1.10
Semliki Forest virus-specific nonstructural protein is associated with ribosomes. FEBS Lett (1979) 1.05
Hypersensitivity reactions to ampicillin in cytomegalovirus mononucleosis. Scand J Infect Dis (1970) 1.05
Multiple structurally related defective-interfering RNAs formed during undiluted passages of Semliki forest virus. Virology (1981) 1.04
Fusion of Semliki Forest virus with red cell membranes. Virology (1981) 1.01
Reversible defect in the glycosylation of the membrane proteins of Semliki Forest virus ts-1 mutant. Virology (1981) 1.00
Inhibition of the membrane fusion machinery prevents exit from the TGN and proteolytic processing by furin. FEBS Lett (2001) 0.99
Virus-specific capping of tobacco mosaic virus RNA: methylation of GTP prior to formation of covalent complex p126-m7GMP. FEBS Lett (1999) 0.98
Cytomegalovirus infection in previously healthy adults. Ann Intern Med (1973) 0.98
Structural complexity of defective-interfering RNAs of Semliki Forest virus as revealed by analysis of complementary DNA. Nucleic Acids Res (1981) 0.98
Analysis of Semliki-Forest-virus structural proteins to illustrate polyprotein processing of alpha viruses. Eur J Biochem (1980) 0.97
Efficient transport of Semliki Forest virus glycoproteins through a Golgi complex morphologically altered by Uukuniemi virus glycoproteins. EMBO J (1986) 0.95
Temperature-dependent internalization of virus glycoproteins in cells infected with a mutant of Semliki Forest virus. EMBO J (1982) 0.95
A single amino acid change in E3 of ts1 mutant inhibits the intracellular transport of SFV envelope protein complex. Virology (1990) 0.95
Synthesis and processing of Semliki Forest virus-specific nonstructural proteins in vivo and in vitro. Eur J Biochem (1980) 0.94
Enrichment of gangliosides in plasma membranes of hamster kidney fibroblasts. Acta Chem Scand (1970) 0.92